Literature DB >> 30834641

A Singular System with Precise Dosing and Spatiotemporal Control of CRISPR-Cas9.

Debasish Manna1,2,3, Basudeb Maji1,2,3, Soumyashree A Gangopadhyay1,2,3, Kurt J Cox1, Qingxuan Zhou1, Benjamin K Law1, Ralph Mazitschek1,2,4,5, Amit Choudhary1,2,3.   

Abstract

Several genome engineering applications of CRISPR-Cas9, an RNA-guided DNA endonuclease, require precision control of Cas9 activity over dosage, timing, and targeted site in an organism. While some control of Cas9 activity over dose and time have been achieved using small molecules, and spatial control using light, no singular system with control over all the three attributes exists. Furthermore, the reported small-molecule systems lack wide dynamic range, have background activity in the absence of the small-molecule controller, and are not biologically inert, while the optogenetic systems require prolonged exposure to high-intensity light. We previously reported a small-molecule-controlled Cas9 system with some dosage and temporal control. By photocaging this Cas9 activator to render it biologically inert and photoactivatable, and employing next-generation protein engineering approaches, we have built a system with a wide dynamic range, low background, and fast photoactivation using a low-intensity light while rendering the small-molecule activator biologically inert. We anticipate these precision controls will propel the development of practical applications of Cas9.
© 2019 Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim.

Entities:  

Keywords:  CRISPR-Cas9; genome editing; photocaging; transcription; trimethoprim

Year:  2019        PMID: 30834641      PMCID: PMC7067309          DOI: 10.1002/anie.201900788

Source DB:  PubMed          Journal:  Angew Chem Int Ed Engl        ISSN: 1433-7851            Impact factor:   15.336


  38 in total

1.  Optical Control of CRISPR/Cas9 Gene Editing.

Authors:  James Hemphill; Erin K Borchardt; Kalyn Brown; Aravind Asokan; Alexander Deiters
Journal:  J Am Chem Soc       Date:  2015-04-23       Impact factor: 15.419

2.  Fabrication and application of flexible, multimodal light-emitting devices for wireless optogenetics.

Authors:  Jordan G McCall; Tae-Il Kim; Gunchul Shin; Michael R Bruchas; John A Rogers; Xian Huang; Yei Hwan Jung; Ream Al-Hasani; Fiorenzo G Omenetto
Journal:  Nat Protoc       Date:  2013-11-07       Impact factor: 13.491

Review 3.  Development and applications of CRISPR-Cas9 for genome engineering.

Authors:  Patrick D Hsu; Eric S Lander; Feng Zhang
Journal:  Cell       Date:  2014-06-05       Impact factor: 41.582

Review 4.  CRISPR/Cas9 in Genome Editing and Beyond.

Authors:  Haifeng Wang; Marie La Russa; Lei S Qi
Journal:  Annu Rev Biochem       Date:  2016-04-25       Impact factor: 23.643

5.  CRISPR-Cas9-guided oncogenic chromosomal translocations with conditional fusion protein expression in human mesenchymal cells.

Authors:  Fabio Vanoli; Mark Tomishima; Weiran Feng; Khadija Lamribet; Loelia Babin; Erika Brunet; Maria Jasin
Journal:  Proc Natl Acad Sci U S A       Date:  2017-03-21       Impact factor: 11.205

6.  A general chemical method to regulate protein stability in the mammalian central nervous system.

Authors:  Mari Iwamoto; Tomas Björklund; Cecilia Lundberg; Deniz Kirik; Thomas J Wandless
Journal:  Chem Biol       Date:  2010-09-24

7.  Destabilizing domains derived from the human estrogen receptor.

Authors:  Yusuke Miyazaki; Hiroshi Imoto; Ling-chun Chen; Thomas J Wandless
Journal:  J Am Chem Soc       Date:  2012-02-22       Impact factor: 15.419

8.  p53 inhibits CRISPR-Cas9 engineering in human pluripotent stem cells.

Authors:  Robert J Ihry; Kathleen A Worringer; Max R Salick; Elizabeth Frias; Daniel Ho; Kraig Theriault; Sravya Kommineni; Julie Chen; Marie Sondey; Chaoyang Ye; Ranjit Randhawa; Tripti Kulkarni; Zinger Yang; Gregory McAllister; Carsten Russ; John Reece-Hoyes; William Forrester; Gregory R Hoffman; Ricardo Dolmetsch; Ajamete Kaykas
Journal:  Nat Med       Date:  2018-06-11       Impact factor: 53.440

9.  CRISPR-Cas9 genome editing induces a p53-mediated DNA damage response.

Authors:  Emma Haapaniemi; Sandeep Botla; Jenna Persson; Bernhard Schmierer; Jussi Taipale
Journal:  Nat Med       Date:  2018-06-11       Impact factor: 53.440

Review 10.  Nuclease-Mediated Gene Therapies for Inherited Metabolic Diseases of the Liver.

Authors:  Taylor E Bryson; Caitlin M Anglin; P Hudson Bridges; Renee N Cottle
Journal:  Yale J Biol Med       Date:  2017-12-19
View more
  11 in total

1.  Visible-to-NIR-Light Activated Release: From Small Molecules to Nanomaterials.

Authors:  Roy Weinstain; Tomáš Slanina; Dnyaneshwar Kand; Petr Klán
Journal:  Chem Rev       Date:  2020-10-30       Impact factor: 60.622

2.  Simultaneous Control of Endogenous and User-Defined Genetic Pathways Using Unique ecDHFR Pharmacological Chaperones.

Authors:  Prerana Ramadurgum; DaNae R Woodard; Steffi Daniel; Hui Peng; Prema L Mallipeddi; Hanspeter Niederstrasser; Melina Mihelakis; Viet Q Chau; Peter M Douglas; Bruce A Posner; John D Hulleman
Journal:  Cell Chem Biol       Date:  2020-04-23       Impact factor: 8.116

Review 3.  Controlling and enhancing CRISPR systems.

Authors:  Haridha Shivram; Brady F Cress; Gavin J Knott; Jennifer A Doudna
Journal:  Nat Chem Biol       Date:  2020-12-16       Impact factor: 15.040

Review 4.  Photo-controllable bioorthogonal chemistry for spatiotemporal control of bio-targets in living systems.

Authors:  Jinbo Li; Hao Kong; Chenghong Zhu; Yan Zhang
Journal:  Chem Sci       Date:  2020-03-10       Impact factor: 9.825

5.  Efficient Genome Editing in Bacillus licheniformis Mediated by a Conditional CRISPR/Cas9 System.

Authors:  Youran Li; Hanrong Wang; Liang Zhang; Zhongyang Ding; Sha Xu; Zhenghua Gu; Guiyang Shi
Journal:  Microorganisms       Date:  2020-05-17

6.  Non-antibiotic Small-Molecule Regulation of DHFR-Based Destabilizing Domains In Vivo.

Authors:  Hui Peng; Viet Q Chau; Wanida Phetsang; Rebecca M Sebastian; M Rhia L Stone; Shyamtanu Datta; Marian Renwick; Yusuf T Tamer; Erdal Toprak; Andrew Y Koh; Mark A T Blaskovich; John D Hulleman
Journal:  Mol Ther Methods Clin Dev       Date:  2019-08-15       Impact factor: 6.698

7.  Chemogenetic System Demonstrates That Cas9 Longevity Impacts Genome Editing Outcomes.

Authors:  Vedagopuram Sreekanth; Qingxuan Zhou; Praveen Kokkonda; Heysol C Bermudez-Cabrera; Donghyun Lim; Benjamin K Law; Benjamin R Holmes; Santosh K Chaudhary; Rajaiah Pergu; Brittany S Leger; James A Walker; David K Gifford; Richard I Sherwood; Amit Choudhary
Journal:  ACS Cent Sci       Date:  2020-11-18       Impact factor: 14.553

Review 8.  Spatiotemporal control of CRISPR/Cas9 gene editing.

Authors:  Chenya Zhuo; Jiabin Zhang; Jung-Hwan Lee; Ju Jiao; Du Cheng; Li Liu; Hae-Won Kim; Yu Tao; Mingqiang Li
Journal:  Signal Transduct Target Ther       Date:  2021-06-20

9.  Thiocoumarin Caged Nucleotides: Synthetic Access and Their Photophysical Properties.

Authors:  Jiahui Ma; Alexander Ripp; Daniel Wassy; Tobias Dürr; Danye Qiu; Markus Häner; Thomas Haas; Christoph Popp; Dominik Bezold; Sabine Richert; Birgit Esser; Henning J Jessen
Journal:  Molecules       Date:  2020-11-15       Impact factor: 4.411

10.  Genome-editing prodrug: Targeted delivery and conditional stabilization of CRISPR-Cas9 for precision therapy of inflammatory disease.

Authors:  Xiaojie Yan; Qi Pan; Huhu Xin; Yuxuan Chen; Yuan Ping
Journal:  Sci Adv       Date:  2021-12-08       Impact factor: 14.136

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.